Stetson Van Matre Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

University of Central Arkansas

unknown

2 h-index 5 pubs 8 cited

Research Areas

Cancer Treatment and Pharmacology Pancreatic and Hepatic Oncology Research Nanoparticles: synthesis and applications Diet and metabolism studies Carcinogens and Genotoxicity Assessment Health and Medical Research Impacts

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Stetson Van Matre's research focuses on investigating novel therapeutic strategies for cancer, particularly pancreatic cancer. His work includes exploring the radiosensitization of cancer cells through the inhibition of specific molecular targets, such as Cyclin-dependent kinase 1 (CDK1). Van Matre has also investigated the potential of methionine restriction to radiosensitize KRAS mutant rectal cancer. His recent publications highlight the use of targeted nanoparticles, specifically amyloid-targeting gold nanoparticles, to rescue pancreatic islet beta-cells from amyloid fibrils and restore insulin homeostasis, suggesting potential applications in therapy. Van Matre collaborates with researchers from the University of Arkansas for Medical Sciences and the University of Arkansas at Little Rock, contributing to a network of shared research interests in oncology and cellular biology. His scholarship metrics include an h-index of 2 and a total of 5 publications.

Metrics

  • h-index: 2
  • Publications: 5
  • Citations: 8

Selected Publications

  • Amyloid Targeting-Gold Nanoparticles-Assisted X-ray Therapy Rescues Islet β-Cells from Amyloid Fibrils and Restores Insulin Homeostasis (2025) DOI
  • Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1 (2024) DOI
  • Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1 (2024) DOI
  • Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer (2023) DOI

Collaborators

Researchers in the database who share publications

Robin Eluvathingal University of Arkansas for Medical Sciences 2 shared publications Henrique Rodrigues University of Arkansas for Medical Sciences 2 shared publications Óscar Zúñiga University of Arkansas at Little Rock 2 shared publications Lokesh Akana University of Arkansas for Medical Sciences 2 shared publications Nükhet Aykin‐Burns University of Arkansas for Medical Sciences 1 shared publication Isabelle Racine Miousse University of Arkansas for Medical Sciences 1 shared publication Oscar Zuniga University of Arkansas for Medical Sciences 1 shared publication Sarita Garg University of Arkansas for Medical Sciences 1 shared publication

Similar Researchers

Based on overlapping research topics

Oscar Zuniga University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Pancreatic and Hepatic Oncology Research Diet and metabolism studies
Good match 4 shared topics
Christopher Salmon University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology Nanoparticles: synthesis and applications Health and Medical Research Impacts
Good match 3 shared topics
Nabeel Alwan University of Arkansas at Little Rock
Cancer Treatment and Pharmacology Nanoparticles: synthesis and applications Health and Medical Research Impacts
Good match 3 shared topics
G. Fletcher University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology Nanoparticles: synthesis and applications Health and Medical Research Impacts
Good match 3 shared topics
Maribel Tirado Gomez University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Carcinogens and Genotoxicity Assessment Health and Medical Research Impacts
Good match 3 shared topics
Robert Kiss University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Carcinogens and Genotoxicity Assessment Health and Medical Research Impacts
Good match 3 shared topics